Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04457375 · ClinicalTrials.gov registry record
Skin Biophysical Measures for Assessing Head and Neck Cancer-Related External Lymphedema
A clinical trial, sponsored by Nova Southeastern University.
- Completed
- Registry status
- 70
- Enrollment target
NCT04457375: Completed study, sponsored by Nova Southeastern University.
NCT04457375 is a clinical trial that has completed, run by Nova Southeastern University. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04457375 has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
Selected measurements in healthy persons of skin tissue dielectric constant as reference values for subsequent use to evaluate patients with head and neck lymphedema.
Primary Outcome
Neck-to-Arm TDC ratio
Interventions
- DIAGNOSTIC_TEST TDC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2021-01-15 |
What the finished NCT04457375 record still lists
NCT04457375 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which TDC is the first listed.
NCT04457375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04457375 about?
NCT04457375 is a clinical study titled "Skin Biophysical Measures for Assessing Head and Neck Cancer-Related External Lymphedema". Selected measurements in healthy persons of skin tissue dielectric constant as reference values for subsequent use to evaluate patients with head and neck lymphedema.
What is the current status of trial NCT04457375?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2020-01-16. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT04457375?
The interventions under investigation include: TDC (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04457375?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI